Director Drummond sells 384k shares for $4.6M; stock up 20% in 30 days but company unprofitable with negative earnings.
Director Robert Wayne Drummond Jr. sold approximately 384,000 shares across two transactions in May, raising $4.6 million. This is notable because the stock has climbed significantly over the past month, yet Drummond chose to sell into that strength despite the company reporting negative earnings in both recent quarters. His own track record at this ticker is mixed: three of his four prior sales at Patterson UTI were well-timed, with the stock falling afterward, but one was poorly timed as shares rose. The company's fundamentals remain challenged—recent quarterly results show continued losses and revenue declining year-over-year—which may explain why Drummond is reducing exposure even as the stock price has recovered. This is a repeat seller; these are his 12th and 13th open-market sales in the past three years, suggesting a consistent pattern of trimming rather than accumulation.